Outcome of Carbon Dioxide Versus Air Insufflations During Endoscopic Retrograde Cholangiopancreatography (ERCP)

NCT01321203 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2011-07-19

No results posted yet for this study

Summary

To assess the safety and efficacy of CO2 insufflations during ERCP

1. Primary objective:

To assess the patient's symptoms, abdominal pain and abdominal distension post procedure (ERCP) in the study group.
2. Secondary objective:

Endoscopist:

* To assess the adequacy of bowel distension for adequate luminal visualization
* To assess the peristaltic movement during the ERCP

Anesthetist:

* To measure the PCO2 level in patient post procedure.
* To assess the amount of sedation required during the procedure.
* To assess saturation and vital signs through out the procedure.
* To assess requirement of buscopan.

Conditions

  • Obstructive Jaundice

Sponsors & Collaborators

  • Asian Institute of Gastroenterology, India

    lead OTHER

Principal Investigators

  • Saravanan Arjuanan, MD · Asian Institute of Gastroenterology, India

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • India

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01321203 on ClinicalTrials.gov